MedTrace Logo

Simvastatin Effect on Radiation Therapy of Brain Metastases

NCT02104193 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-02-17

No results posted yet for this study

Summary

The purpose of the study is to evaluate the effect of simvastatin in combination with radiotherapy on the clinical outcomes of patients with brain metastases.

Conditions

Interventions

DRUG

simvastatin in addition to radiation therapy

simvastatin 80 mg tablet once daily during the radiation therapy period in addition to radiation therapy 30 Gy delivered in 10 fractions over 2 weeks

RADIATION

radiation therapy

radiation therapy 30 Gy delivered in 10 fractions over 2 weeks

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • May A Shawki, master · Faculty of Pharmacy- Ain Shams university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-11-30
Completion
2015-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02104193 on ClinicalTrials.gov